Skip to main navigation Skip to search Skip to main content

A phase 3, multicenter, placebocontrolled, randomized, observer-blinded trial to evaluate the efficacy, safety, tolerability,

Project: Research

Project Details

StatusFinished
Effective start/end date10/17/22 → 10/16/23

Funding

  • Pfizer Incorporated: $17,194.00